MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
ADC Therapeutics SA

ADCT

#2431
ADC Therapeutics SA
4.12
+0.49%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
4.09
4.16
Intervallo Annuale
1.05
4.80
Variazione giornaliera
+0.49%
Variazione Mensile
+14.76%
Variazione di 6 mesi
+26.77%
Variazione Annuale
+143.79%
Chiusura Precedente
4.10
Open
4.10
Bid
Ask
Low
4.09
High
4.16
Volume
184
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. ADCT
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Notizie

Investing Investing
ADCT
2026.02.23
ADC Therapeutics gibt Optionsscheine an Healthcare Royalty aus/n
Investing Investing
ADCT
2026.02.23
ADC Therapeutics grants warrants to Healthcare Royalty
Investing Investing
ADCT
2026.02.23
ADC Therapeutics passt Lizenzgebührenvereinbarung an und senkt Zahlung bei Kontrollwechsel
Investing Investing
ADCT
2026.02.23
ADC Therapeutics amends royalty deal with HealthCare Royalty
Zacks Zacks
ADCT
2026.01.30
Has ADC Therapeutics (ADCT) Outpaced Other Medical Stocks This Year?
Zacks Zacks
ADCT AGEN
2026.01.13
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?
Zacks Zacks
ADCT
2025.12.29
ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why
Zacks Zacks
ADCT CPRX
2025.12.17
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?
Zacks Zacks
ADCT
2025.12.15
ADC Therapeutics SA (ADCT) is a Great Momentum Stock: Should You Buy?
Benzinga Benzinga
SNOW NLOP SYM CAPR ADCT
2025.12.04
Snowflake, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - ADC Therapeutics (NYSE:ADCT), Capricor Therapeutics (NASDAQ:CAPR)
Investing Investing
ADCT
2025.12.03
ADC Therapeutics: RBC bestätigt "Outperform"-Rating nach starken Studiendaten
Investing Investing
ADCT
2025.12.03
ADC Therapeutics stock maintains Outperform rating at RBC on strong trial data

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd